THE BUPA STARTUP STAGE
The Bupa Startup Stage will run alongside the Main Stage talks at WIRED Health. Here, a wide range of growth-stage businesses working in the health sector will introduce their organisations and explain their objectives, aims and applications. The Bupa Startup Stage talks will offer insight into the thrills and difficulties of forming a new business, as well being the perfect platform to meet tomorrow’s health sector game changers.
To give you an idea of the types of businesses that will appear on the Bupa Startup Stage, the WIRED Health 2014 startups are listed below.
Keira Barr, A.R.O., Inc.
A.R.O., Inc. is a contextual intelligence company based in Seattle, Washington that builds apps such as Brightly to help people lead happier, healthier, and generally more amazing lives. A.R.O. was founded on the belief that apps should be positive forces for change. Brightly uses geolocation and indoor/outdoor tracking to measure your UV exposure, calculate your individual risk for skin damage such as melanoma, provide accumulated UV exposure over weeks and months, and warn users when UV exposure levels have become dangerous.
Ami Karnik, Azoi Inc.
Azoi is a technology company dedicated to helping people improve their lives. Azoi’s team of designers, scientists and thinkers draw from the world in which we live to create products that enhance our lives without getting in the way of living it. Wello, its first product, is a mobile health tracker disguised as a smartphone cover that quickly, accurately and easily measures vitals instantaneously syncing the data to an accompanying iPhone or Android app. To learn more, visit:
Peter Hames, Big Health
Big Health is the pioneering healthcare company that delivers personalised behavioural medicine via web and mobile to the highest standards of clinical evidence. Its first product, Sleepio, is a digital sleep improvement programme.
Jen Hyatt, Big White Wall
Big White Wall is a digital mental health and wellbeing service. Its community enables members to self-manage their care, with the collaboration of clinicians and peers, through a choice of therapeutic services available 24/7 via mobile, tablet and PC devices. Designated a “High Impact Innovation” by the NHS, it covers the UK and New Zealand, with contracts covering 27 percent of UK adults. The operation expects reach additional markets, including the US, in 2014.
David Plans, BioBeats
Using an iPhone camera, BioBeats can generate “experiental” music dynamically created from its user’s heartbeat. It gives the user biological information about how their body is operating and can highlight over- exertion or states of stress. BioBeats works by reading blood flow as it enters a person’s finger, using the beat as a basis of musical composition.
Fiona Nielson, DNAdigest
The output of DNA sequenced data is increasing exponentially, however sharing and accessing this data remains difficult. This wastes public funding, holds back research and treatments. DNAdigest is a social enterprise that’s building a software platform and open API to provide secure queries across genetic databases that delivers immediate anonymised results. Using this platform it hopes to accelerate genetics research.
Olga Kubassova, Image Analysis
The identification and tracking of localised inflammatory disease in the human body by MRI is a rapidly growing area in medicine. Diagnosis and treatment decisions increasingly depend on MRI images. But there is often little or no sensitive quantitative measurement of the original lesion or its response to drug treatment. This is the gap being filled by Image Analysis, which is involved in international clinical trials and in use at major clinical institutes in EU and USA.
Gilad Gome, mirOculus
mirOculus has developed a test that detects microRNA in the bloodstream, allowing for early diagnosis of cancerous tumours. The technology means that a single, non-invasive blood test can screen for multiple cancers, cheaply and accurately, in less than an hour. The results of each sample are recorded in real time and get sent to mirOculus servers, allowing for the creation of a microRNA database to identify correlations and causations of several diseases.
Sofia Svanteson, Ocean Observations
Ocean Observations is a digital design agency based in Stockholm and Tokyo. Many of its clients work in the technology and health sector. Its most recent projects include helping Karolinska Institutet, a Swedish a medical university, to design an online screening for early diagnosis of chronic diseases; and developing a concept for Riskminder, a risk analysis firm, in which citizens detect their likelihood of developing chronic diseases based on genetics and lifestyle.
Andrew Bastawrous, Peek
Acronym for portable eye examination kit, Peek is a smartphone-based system that carries out a full range of ophthalmic diagnostic tests. It’s the brainchild of a team of ophthalmologists, developers and engineers from the London School of Hygiene & Tropical Medicine, the University of Strathclyde and the Glasgow Centre for Ophthalmic Research. Peek detects a range of visual deficiencies from blindness and visual impairment, to cataracts, glaucoma, macular degeneration and others.
Martín Blinder, Tictrac
Tictrac is a personal analytics platform that allows people to take control of their data, display it in a dashboard and use it to inform better life decisions. The idea is to gather data from multiple sources – such as apps and manual input – and collate it for better time management and to help achieve goals, such as losing weight.
Jean Nehme, Touch Surgery
Touch Surgery uses cognitive-task analysis to help medical students. The digital lessons rely on vivid and realistic 3D environments to improve understanding of complex surgical procedures. Touch Surgery keeps track of students’ training progress, plots learning curves and helps them work on their weaker medical skills.
Pablo Graiver, TrialReach
There is a problem in drug development. It takes too long and costs too much to develop effective, new medical treatments. This is in part because researchers can’t find the patients they need to complete their clinical trials. TrialReach.com is an open platform connecting patients with medical researchers conducting clinical trials. The approach has led to Forbes to assert that, by bridging the gap between researchers and patients, TrialReach is democratising clinical trials.
Marco Peluso, Qardio
Qardio is a technology company focused on heart health monitoring and its innovation. Qardio’s two devices, QardioArm and QardioCore, were developed using proprietary technologies, user friendly features and create a base of the Qardio health platform. Qardio’s mission is to create smart, beautifully designed products people will want to use. We believe that medical devices that are easy to use, look great, work well and provide robust accurate data are the ones users will love to have and doctors will find useful.
Josipa Majic, Teddy the Guardian
Teddy the Guardian is a plush teddy bear with built-in medical sensors to track a child’s temperature, heart rate and oxygen levels through “smart paws”, upon contact. Being sick, visiting the doctor or hospital can make even the bravest of us uncomfortable. These feelings are multiplied in children, making parents and guardians more anxious. Teddy the Guardian is designed to support children, parents – even physicians – in making the medical care less stressful.
Juuso Nissilä, VALKEE Oy
Finnish medical technology company Valkee has developed a portable bright light headset, to replicate the mood-elevating effects of sunlight. It works by channeling bright light directly to photosensitive regions of the brain through the ear canal and skull. Valkee claims it can alleviate seasonal depression and its symptoms. Valkee has a medical device approval in class 2(a) with CE-certification in the EU. Clinical studies are underway to fully understand Valkee’s benefits.
Satoshi Sugie, WHILL
Mobility scooters and wheelchairs, have an image problem. WHILL is dedicated to designing and building the next generation of personal mobility devices and breaking the stigma attached to such devices. WHILL’s Type-A is compact, highly manoeuvrable and features a four-wheel drive system. It also forces the user to sit in an upright and ‘active’ position. It has three speeds and is driven by a mouse-like controller. CEO Satoshi Sugie previously worked at the NISSAN Technical Centre in Japan.